scholarly journals Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis

2020 ◽  
Vol 12 (3) ◽  
pp. 241
Author(s):  
Wisit Kaewput ◽  
Charat Thongprayoon ◽  
NadeenJ Khoury ◽  
Tarun Bathini ◽  
NarothamaReddy Aeddula ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Parvovirus B19 ◽  
Meta Analysis ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

scholarly journals Coronavirus disease 2019 in kidney transplant recipients: a systematic review and meta-analysis

2021 ◽  
Author(s):  
QY Ho ◽  
R Sultana ◽  
TL Lee ◽  
S Thangaraju ◽  
T Kee ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Clinical Presentation ◽  
Meta Analysis ◽  
Kidney Injury ◽  
High Dose ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Presenting Symptoms ◽  
Effect Of Treatment ◽  
Dose Corticosteroid

Introduction: The clinical presentation and outcomes of coronavirus disease 2019 (COVID-19) in kidney transplant recipients (KTRs) have not been well studied. Methods: We performed a meta-analysis to examine the presenting features, outcomes and the effect of treatment on outcomes of KTRs with COVID-19. Database search was performed up to 5 September 2020 through PubMed, EMBASE, Web of Science, SCOPUS, and CENTRAL. Results: Overall, 23 studies (1373 patients) were included in the review and meta-analysis. The most common presenting symptoms included fever (74.0%, 95% confidence interval [CI] 65.3–81.1), cough (63.3% 95% CI 56.5–69.6) and dyspnoea (47.5%, 95% CI 39.6–55.6). Pooled rates of mortality and critical illness were 21.1% (95% CI 15.3-28.4) and 27.7% (95% CI 21.5–34.8) respectively. Acute kidney injury occurred in 38.9% (95% CI 30.6–48.1) and dialysis was required in 12.4% (95% CI 8.3–18.0) of the cases. Discussion: KTRs with COVID-19 have a similar clinical presentation as the general population but have higher morbidity and mortality. It is uncertain whether high dose corticosteroid or hydroxychloroquine reduces the risks of mortality in KTRs with COVID-19.

Cognition in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.

2014 ◽  
Vol 98 ◽  
pp. 845-846 ◽  
Author(s):  
P. Masson ◽  
S. Wu ◽  
F. Duthie ◽  
S. Palmer ◽  
G. Strippoli ◽  
...  
Keyword(s):  
Systematic Review ◽  
Kidney Transplant ◽  
Meta Analysis ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

Prevalence and Antimicrobial Resistance of Bacterial Uropathogens Isolated from Iranian Kidney Transplant Recipients: A Systematic Review and Meta-Analysis

2020 ◽  
Author(s):  
Abbas SHAPOURI MOGHADDAM ◽  
Maryam ARFAATABAR ◽  
Jalil TAVAKOL AFSHARI ◽  
Ali SHAKERIMOGHADDAM ◽  
Zahra MOHAMMADZAMANI ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Kidney Transplant ◽  
Meta Analysis ◽  
Klebsiella Pneumonia ◽  
Infection Prevalence ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Gram Negative ◽  
E Coli ◽  
Iranian Patients

Background: Urinary tract infection (UTI) is a major complication in patients who receive the kidney transplant. We aimed to evaluate the prevalence and antimicrobial resistance of bacterial uropathogens isolated from Iranian kidney transplant recipients. Methods: We searched according to Prisma protocol for UTI infection, prevalence, occurrence and distribution of bacteria and their pattern of antibiotic resistance among Iranian patients who receive kidney transplant through online electronic databases with MeSh terms and text words in published references in both Persian and English languages during 1990-2017. Data analysis was performed using Comprehensive meta-analysis software (CMA) by Cochrane Q and I2 Random Effects Model. Results: Eleven studies met the eligible inclusion criteria. The prevalence of UTI among kidney transplant patients varied from 11.7% to 67.5%. The combined prevalence of UTI was 32.6%. Among Gram-negative pathogens causing UTI, E. coli was the most dominant followed by Klebsiella pneumonia with prevalence 41.3% and 11.9%, respectively. Also, amongst Gram-positive bacteria, the highest prevalence belonged to Enterococcus spp. (9.8%) and coagulase-negative Staphylococci (9.4%). Also in Gram-negative pathogens, the most resistance was to ampicillin (91.2%), followed by ceftazidime (89.5%). The minimum resistance was against imipenem with prevalence 14.3%. Conclusion: The combined prevalence of UTI was 32.6%. Gram-negative pathogens especially E. coli were the most agents of UTI in Iranian patients who receive kidney transplant. Also, in gram-negative pathogens, the most resistance was to ampicillin that it needs a new strategy for prophylaxis and treatment of UTI after the kidney transplant.

scholarly journals Bisphosphonates for preventing bone disease in kidney transplant recipients: a meta-analysis of randomized controlled trials

2015 ◽  
Vol 29 (2) ◽  
pp. 153-164 ◽  
Author(s):  
Emmanuelle B. Versele ◽  
Steven Van Laecke ◽  
Annemieke W. Dhondt ◽  
Francis Verbeke ◽  
Raymond Vanholder ◽  
...  
Keyword(s):  
Randomized Controlled Trials ◽  
Kidney Transplant ◽  
Bone Disease ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Randomized Controlled

Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis

2016 ◽  
Vol 30 (9) ◽  
pp. 1090-1096 ◽  
Author(s):  
Stephanie M. Toth-Manikowski ◽  
Jean M. Francis ◽  
Amitabh Gautam ◽  
Craig E. Gordon
Keyword(s):  
Systematic Review ◽  
Kidney Transplant ◽  
Meta Analysis ◽  
Bisphosphonate Therapy ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document